Ophthalmology Times: January 2021

February 10, 2021

Investigators focus on biophysical method to study protein-protein interactions .

February 09, 2021

While current treatments are good, the best is yet to come.

February 08, 2021

Drops can simplify dosing, improving adherence and ocular surface health

February 05, 2021

Consider ideas about outflow pathways, neuroprotection.

February 04, 2021

Investigators examine long-term effects of therapeutics in infants.

February 02, 2021

Peptides offering ophthalmologists a potential treatment option for keratitis.

February 01, 2021

Once-daily corticosteroid treats pain, inflammation after surgery.

January 29, 2021

Noninvasive option reduces IOP in patients with glaucoma.

January 28, 2021

Community involvement, research continue to boost treatment in pediatric population.

January 27, 2021

Emerging technology may facilitate individualized care, disease management.

January 26, 2021

Organization shines spotlight on frontline heroes during ongoing COVID-19 battle.

January 25, 2021

For ophthalmologists, practice makes perfect in becoming ambidextrous.

January 22, 2021

Physician pioneers technique offering higher perspective in surgery, outcomes.

January 20, 2021

Sometimes, physicians may find that falling behind is the right thing to do.

January 05, 2021

Minimally invasive conjunctival surgery option is an efficient procedure.

January 03, 2021

Study supports preoperative ocular surface optimization with artificial tears.

December 31, 2020

All syringes used for intravitreal injections have pros and cons. Some recently marketed and forthcoming products are coming closer to meeting “ideal” criteria.